» Articles » PMID: 23237036

Treatments of Vitiligo: What's New at the Horizon

Overview
Journal Dermatol Ther
Specialty Dermatology
Date 2012 Dec 15
PMID 23237036
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Vitiligo is a manageable disease. However, current vitiligo treatments can be considered suboptimal as they do not guarantee high efficacy and cannot be standardized for most patients. Recently, combination therapies have been introduced in order to obtain better results and reduce risks in the management of the disease. Novel efficacious products are hereunder discussed to improve the therapeutic options for vitiligo patients.

Citing Articles

Efficacy of prostaglandin E2 versus prostaglandin F2 alpha assisted with narrowband-UVB in stable vitiligo.

Neinaa Y, Mahmoud M, El Maghraby G, Ibrahim Z Arch Dermatol Res. 2023; 315(9):2647-2653.

PMID: 37594537 PMC: 10514142. DOI: 10.1007/s00403-023-02700-8.


Thunb. Extract Stimulates Melanogenesis by Induction of COX2 Expression through the Activation of p38 MAPK in B16F10 Mouse Melanoma Cells.

Kim D, Kim H, Jun H Evid Based Complement Alternat Med. 2020; 2020:7642019.

PMID: 32714420 PMC: 7334760. DOI: 10.1155/2020/7642019.


Autologous Fat Graft: Not Only an Aesthetic Solution.

Scala J, Vojvodic A, Vojvodic P, Vlaskovic-Jovicevic T, Peric-Hajzler Z, Matovic D Open Access Maced J Med Sci. 2019; 7(18):2961-2963.

PMID: 31850099 PMC: 6910800. DOI: 10.3889/oamjms.2019.781.


Micro - Focused Phototherapy Associated To Janus Kinase Inhibitor: A Promising Valid Therapeutic Option for Patients with Localized Vitiligo.

Gianfaldoni S, Tchernev G, Wollina U, Roccia M, Fioranelli M, Lotti J Open Access Maced J Med Sci. 2018; 6(1):46-48.

PMID: 29483979 PMC: 5816312. DOI: 10.3889/oamjms.2018.042.


Combination therapy of orally administered glycyrrhizin and UVB improved active-stage generalized vitiligo.

Mou K, Han D, Liu W, Li P Braz J Med Biol Res. 2016; 49(8).

PMID: 27464024 PMC: 4964896. DOI: 10.1590/1414-431X20165354.